Aptar to introduce innovative respiratory solutions at Cphl

Pharma trade and networking platform in China


Aptar Pharma, a global solution provider in the design, development and manufacturing of proven drug delivery devices for biotech, healthcare and pharma partners , will be exhibiting at Cphl China, Asia’s leading trade and networking platform, between 20 and 22 June 2018 at the Shanghai New International Exhibition Center, Shanghai, China. Cphl China has invited the entire pharma industry chain of 40,000 experts from over 120 countries to network and collaborate on the forthcoming trends for China’s pharma market.

Aptar Pharma will display new market innovations in inhalation drug delivery for respiratory solutions to combat the effects of air pollution in China.

In addition, the company will also exhibit its innovative Connected Device portfolio for respiratory and eye care. The exhibition will offer visitors a chance to explore the innovative devices featuring fully-connected functionality and software integration for improving patient health outcomes.

Aptar Pharma will also display its drug delivery systems expertise in dermal innovation. Specialists will be on hand to discuss the newly enhanced dispensing solutions for Aptar Pharma’s Airless Dermal Drug Delivery Systems, providing insight into how their technologies and features can support pharmaceutical professionals’ drug formulations and consumer products.

A seminar will be conducted by Aptar Pharma on 22 June, during which two experts from the company will present two interactive sessions. While Guenter Nadler, director — business development consumer health care division, will talk about ‘Healthy Nose, Healthy Life: A Glance at Global Successful Products for Upper Respiratory Health’, Tianjiao Fu, business development manager China, pharma sales., will make his presentation on ‘Say No to Preservatives: Package Innovation for Ophthalmic & Dermal Products’. The sessions will be followed by a Q&A round.

Commenting on the exhibition, Nadler said, “We are delighted to once again participate in CPhI China, which connects us with the entire Chinese pharmaceutical market. We look forward to showcasing our new market innovations and demonstrating our expertise to industry leaders through our broad drug delivery solutions and our seminar presentations at this event.”

As you join us today from India and elsewhere, we have a favour to ask. Through these times of ambiguity and challenge, the packaging industry in India and in most parts of the world has been fortunate. We are now read in more than 90 countries as our coverage widens and increases in impact. Our traffic as per analytics more than doubled in 2020 and many readers chose to support us financially even when advertising fell to pieces.

As we come out of the pandemic in the next few months, we hope to again expand our geography and evolve our high-impact reporting and authoritative and technical information, with some of the best correspondents in the industry. If there were ever a time to support us, it is now. You can power Packaging South Asia’s balanced industry journalism and help to sustain us by subscribing.

Subscribe Now


Please enter your comment!
Please enter your name here